• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2 S; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2 S; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09289267190
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/21/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys anti-sars-cov-2 s results for two patients tested on a cobas 6000 e 601 module serial number (b)(4).It was requested but not provided if the initial elecsys anti-sars-cov-2 s results were reported outside the laboratory.The customer performed repeat testing with the samples prior to calibration and after calibration, and the results for both samples had increasing values.For repeat testing, the customer did recentrifuge the samples.At 15:34, patient 1's initial elecsys anti-sars-cov-2 s result was 0.400 u/ml with a data flag and non-reactive.The patient's repeat results before calibration were 17 u/ml reactive and 29 u/ml reactive.The patient's result after calibration was 38.73 u/ml reactive.At 15:34, patient 2's initial elecsys anti-sars-cov-2 s result was 0.400 u/ml with a data flag and non-reactive.The patient's repeat result before calibration was 1.99 u/ml reactive.The patient's result after calibration was 2.23 u/ml reactive.
 
Manufacturer Narrative
Calibration, qc, pre-analytical and instrument data were submitted and analyzed.Pre-analytical or reagent handling could not be excluded due to the limited information submitted.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2 S
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12313731
MDR Text Key266252776
Report Number1823260-2021-02353
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EUA202698
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2021
Device Catalogue Number09289267190
Device Lot Number548617
Was Device Available for Evaluation? Yes
Date Manufacturer Received07/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
METFORMIN (PATIENT 1); NEBILET (PATIENT 1); NOVALGIN (PATIENT 1); PANTOPRAZOL (PATIENT 1); SALBUTAMOL (PATIENT 1); METFORMIN (PATIENT 1); NEBILET (PATIENT 1); NOVALGIN (PATIENT 1); PANTOPRAZOL (PATIENT 1); SALBUTAMOL (PATIENT 1)
Patient Age78 YR
-
-